| Patents for G01N 33 - Investigating or analysing materials by specific methods not covered by groups (393,632) |
|---|
| 12/27/2013 | WO2013190867A1 Method for preparing sample containing pancreatic juice component, and kit for storing biological sample containing pancreatic juice component at room temperature |
| 12/27/2013 | WO2013190679A1 Fusion protein, nucleic acid, vector, cell, method for measuring lab, and kit for use in measurement of lab |
| 12/27/2013 | WO2013190582A1 Euglobulin-based method for determining the biological activity of defibrotide |
| 12/27/2013 | WO2013190550A1 Method and system for use in monitoring biological material |
| 12/27/2013 | WO2013190290A1 An oncolytic herpes simplex virus for use in the treatment of cancer |
| 12/27/2013 | WO2013190281A1 Glucose sensor |
| 12/27/2013 | WO2013190262A1 Gas sensor comprising flameproof barrier |
| 12/27/2013 | WO2013190165A1 Compounds having magnetic functionality, implants or gels derived from same, and use of both in order to determine the enzyme activity of an enzyme |
| 12/27/2013 | WO2013190155A1 Disposable diagnostic card and electronic reading device |
| 12/27/2013 | WO2013190127A1 Antagonist to an enzyme and/or a metabolite of the kynurenine pathway |
| 12/27/2013 | WO2013190089A1 Molecular biomarkers for predicting outcome in lung cancer |
| 12/27/2013 | WO2013190075A2 Specific biomarkers for hepatocellular carcinoma (hcc) |
| 12/27/2013 | WO2013190073A1 Analytical test strip with capillary sample-receiving chambers separated by stop junctions |
| 12/27/2013 | WO2013190071A2 Simultaneous measurement of thrombin generation and clot strength in plasma and whole blood |
| 12/27/2013 | WO2013190051A1 Methods and kits for assessing the quality of red blood cells generated in vitro |
| 12/27/2013 | WO2013190041A1 Methods and kits for predicting the survival time of post acute myocardial infarction patients |
| 12/27/2013 | WO2013190029A1 Method for the prognosis of a lymphoma and kit for implementing same |
| 12/27/2013 | WO2013189991A1 Method for the capture or removal of amyloidogenic proteins |
| 12/27/2013 | WO2013189879A1 Sensor and methods for measuring particles in media |
| 12/27/2013 | WO2013189852A1 Method for transcribing an odor or aroma into color information, and method for transcribing color information into a list of molecules |
| 12/27/2013 | WO2013189822A1 Methods for determining the risk of mortality in patients with cardiovascular disease |
| 12/27/2013 | WO2013189778A1 Bag3 as biochemical serum and tissue marker |
| 12/27/2013 | WO2013189775A1 Bag3 as biochemical serum and tissue marker |
| 12/27/2013 | WO2013189722A1 Method and arrangement for detecting cells in a cell suspension |
| 12/27/2013 | WO2013189502A1 A method and a system for quantitative or qualitative determination of a target component |
| 12/27/2013 | WO2013189265A1 Method, system, and kit for detecting potassium ion concentration |
| 12/27/2013 | WO2013188984A1 Systems and methods for identifying thermodynamically relevant polymer conformations |
| 12/27/2013 | WO2013188952A1 Sensor for early detection of problems in algae cultures and related system and method |
| 12/27/2013 | WO2013188927A1 Multiplex suspension assay/array using lifetime coding |
| 12/27/2013 | WO2013188903A1 An apparatus, system and method for actuating downhole tools in subsea drilling operations |
| 12/27/2013 | WO2013166186A8 Method for determining complete response to anticancer therapy |
| 12/27/2013 | WO2013136044A3 Sensor for detecting the amount of analyte in a sample |
| 12/27/2013 | WO2013124482A3 Identification of modulators of binding properties of antibodies reactive with a member of the insulin receptor family |
| 12/27/2013 | WO2013108126A3 Methyltransferases and uses thereof |
| 12/27/2013 | WO2013067448A3 Compositions and methods to detect various infectious organisms |
| 12/27/2013 | WO2012161288A8 Immunoassay methods and reagents for decreasing nonspecific binding |
| 12/27/2013 | WO2012135146A3 Role of ifng methylation in inflammatory bowel disease |
| 12/27/2013 | WO2012135144A3 Methods of diagnosing and treating intestinal granulomas and low bone density in inflammatory bowel disease |
| 12/27/2013 | CA2877459A1 Quick test device and method |
| 12/27/2013 | CA2877427A1 Glucose sensor |
| 12/27/2013 | CA2877315A1 Marker quantitation in single cells in tissue sections |
| 12/27/2013 | CA2877256A1 Systems and methods for identifying thermodynamically relevant polymer conformations |
| 12/27/2013 | CA2877126A1 Method for predicting drug-target interactions and uses for drug repositioning |
| 12/27/2013 | CA2877058A1 Compounds with magnetic functionality, implants or gels derived thereof, and the use of both to measure the enzyme activity of an enzyme |
| 12/27/2013 | CA2876951A1 Methods for head and neck cancer prognosis |
| 12/27/2013 | CA2876931A1 Analytical test strip with capillary sample-receiving chambers separated by stop junctions |
| 12/27/2013 | CA2876922A1 Bag3 as biochemical serum and tissue marker |
| 12/27/2013 | CA2876916A1 Kit for diagnosing malignant melanoma |
| 12/27/2013 | CA2876904A1 Anti-jagged 1/jagged 2 cross-reactive antibodies, activatable anti-jagged antibodies and methods of use thereof |
| 12/27/2013 | CA2876872A1 Bag3 as biochemical serum and tissue marker |
| 12/27/2013 | CA2876820A1 Method for measuring breath alcohol concentration and apparatus therefor |
| 12/27/2013 | CA2876692A1 Method for obtaining fetal cells and fetal cellular components |
| 12/27/2013 | CA2874960A1 Euglobulin-based method for determining the biological activity of defibrotide |
| 12/26/2013 | US20130347137 Stabilized Step Function Opsin Proteins and Methods of Using the Same |
| 12/26/2013 | US20130346007 Characterizing an Elongated Textile Test Material |
| 12/26/2013 | US20130345805 Methods for treating or predicting risk of a ventricular tachyarrhythmia event |
| 12/26/2013 | US20130345581 Combination for early exclusion of acute myocardial infarction |
| 12/26/2013 | US20130345322 Diagnostic for colorectal cancer |
| 12/26/2013 | US20130345306 Identification of c3 complement molecule at the site of injury to blood vessels in the retina of oxygen exposed animals |
| 12/26/2013 | US20130345263 Use of stathmin as a biomarker of drug response to furazanobenzimidazoles |
| 12/26/2013 | US20130345230 Methods and compositions for modulating calcium channels |
| 12/26/2013 | US20130345163 Biological marker for inflammation |
| 12/26/2013 | US20130345144 Use of ID4 for Diagnosis and Treatment of Cancer |
| 12/26/2013 | US20130345141 Composition for regulating circadian rhythms, composition for diagnosing circadian rhythm disorders and diagnostic kit |
| 12/26/2013 | US20130345114 Agent for Treating Allergic or Hypersensitivity Condition |
| 12/26/2013 | US20130345096 Microfluidic Chip Automatic System With Optical Platform |
| 12/26/2013 | US20130345092 T1r taste receptors and genes encoding same |
| 12/26/2013 | US20130345089 Photoactivated chemical bleaching of dyes |
| 12/26/2013 | US20130345088 Bead sealing method, method for detecting target molecule, array, kit, and target molecule detection device |
| 12/26/2013 | US20130345087 Probe for analyzing biological tissue and method for utilizing same |
| 12/26/2013 | US20130345084 Methods and devices for obtaining and analyzing cells |
| 12/26/2013 | US20130345081 Human factor xiii as a normalization control for immunoassays |
| 12/26/2013 | US20130345079 Mycobacterium tuberculosis antigens and combinations thereof having high seroreactivity |
| 12/26/2013 | US20130345078 Methods and arrays for target analyte detection and determination of target analyte concentration in solution |
| 12/26/2013 | US20130345074 Biomarker and method for evaluating risk for Parkinson's disease |
| 12/26/2013 | US20130345073 Use of alpha-2-macroglobulin for determining osteonecrosis disease status and for screening therapeutic agents for preventing or treating osteonecrosis |
| 12/26/2013 | US20130345072 Method of designing addressable array suitable for detection of nucleic acid sequence differences using ligase detection reaction |
| 12/26/2013 | US20130344622 Position adjustment method for movable unit in sample analyzer, and sample analyzer |
| 12/26/2013 | US20130344621 Methods for determining anti-drug antibody isotypes |
| 12/26/2013 | US20130344619 Glucose sensor |
| 12/26/2013 | US20130344606 Heparin Concentration and Heparin Response Imbalance Determination Method Within a Fluid Containing Heparin |
| 12/26/2013 | US20130344605 Method and arrangement for partial labeling and subsequent quantification of cells of cell suspension |
| 12/26/2013 | US20130344582 Method for assaying cell movement |
| 12/26/2013 | US20130344529 Vascular model, method for producing said model and use thereof |
| 12/26/2013 | US20130344519 Methods and systems for assessment of turbidity kinetics (waveform analysis) in coagulation testing |
| 12/26/2013 | US20130344517 Use of galectin-3 for risk assessment and detection of preeclampsia and related conditions |
| 12/26/2013 | US20130344516 Armet as a marker for chronic obstructive pulmonary disease (copd) |
| 12/26/2013 | US20130344515 Radial flow immunoassay and methods of production and use thereof |
| 12/26/2013 | US20130344514 Reducing the risk of human anti-human antibodies through v gene manipulation |
| 12/26/2013 | US20130344513 Risk stratification for acute coronary syndrome by means of fragments/partial peptides of provasopressin, especially copeptin or neurophysin ii |
| 12/26/2013 | US20130344512 Cd16a reporter assay for evaluation of adcc potential of biologics |
| 12/26/2013 | US20130344511 Use of hematopoietic growth factor inducible neurokinin-1 (hgfin) as a novel biomarker |
| 12/26/2013 | US20130344510 Identification of cancer patients likely to benefit from radiation therapy |
| 12/26/2013 | US20130344508 Methods and/or Use of Oligonucleotide Conjugates for Suppressing Background Due to Cross-Hybridization |
| 12/26/2013 | US20130344506 Seprase as a marker for chronic obstructive pulmonary disease (copd) |
| 12/26/2013 | US20130344505 Apex1 as a marker for chronic obstructive pulmonary disease (copd) |
| 12/26/2013 | US20130344504 Nnmt as a marker for chronic obstructive pulmonary disease (copd) |
| 12/26/2013 | US20130344503 Methods for determining the risk of prenatal complications |
| 12/26/2013 | US20130344502 Vibrating microplate biosensing for characterising properties of behaviour biological cells |
| 12/26/2013 | US20130344499 Dyes and methods of marking biological material |